Matching-Adjusted Indirect Comparison of Risankizumab Versus Icotrokinra in Adult Patients with Moderate-to-Severe Plaque Psoriasis - Poll - MDSpire

Matching-Adjusted Indirect Comparison of Risankizumab Versus Icotrokinra in Adult Patients with Moderate-to-Severe Plaque Psoriasis

  • By

  • Jeffrey Crowley

  • Eingun James Song

  • Linda Stein-Gold

  • Paolo Gisondi

  • Christopher G. Bunick

  • Vishvas Garg

  • Emanuele Leoncini

  • Blair Kaplan

  • Richard Ta

  • Bang Truong

  • Dolly Sharma

  • Bruce Strober

  • July 2, 2026

  • 0 min

Share

Original Source(s)

Matching-Adjusted Indirect Comparison of Risankizumab Versus Icotrokinra in Adult Patients with Moderate-to-Severe Plaque Psoriasis

  • by Jeffrey Crowley, Eingun James Song, Linda Stein-Gold, Paolo Gisondi, Christopher G. Bunick, Vishvas Garg, Emanuele Leoncini, Blair Kaplan, Richard Ta, Bang Truong, Dolly Sharma, Bruce Strober

  • July 2, 2026

Related Content

Correction: Association between Life's Essential 8 and psoriasis in US adults: a cross-sectional study

Guselkumab Shows Psoriasis Benefit in Darker Skin Tones

Randomized trial suggests sustained clearance across darker skin tones.

Early Response to Calcipotriol and Betamethasone Dipropionate PAD-Cream at Week 4 in Patients with Mild-to-Moderate Plaque Psoriasis: A Post-Hoc Pooled Analysis of Two Phase III Trials